top of page
Cover Page Articles
JC1.png
JC2.png
Research Articles

​​

​​​

  1. Adhikary S, Singh V, Choudhari R, Yang B, Adhikari S, Ramos EI, Chaudhuri S, Roy S, Gadad SS*, Das C*. 2022. ZMYND8 suppresses MAPT213 LncRNA transcription to promote neuronal differentiation. Cell Death and Disease (2022) 13:766. JIF: 8.469

  2. Sengupta I, Mondal P, Sengupta A, Mondal A, Singh V, Adhikari S, Dhang S, Roy S, Das C. 2022. Epigenetic regulation of Fructose-1,6-bisphosphatase 1 by host transcription factor Speckled 110 kDa during hepatitis B virus infection. FEBS J. 2022 Nov;289(21):6694-6713. JIF: 5.62

  3. Mondal P, Gadad SS, Adhikari S, Ramos EI, Sen S, Prasad P, Das C*. 2021. TCF19 and p53 regulate transcription of TIGAR and SCO2 in HCC for mitochondrial energy metabolism and stress adaptation. FASEB J. 35(9), JIF: 5.191
     

  4. Mukherjee S, Adhikary S, Gadad S.S., Mondal P, Sen S., Choudhari R., Singh V., Adhikari S., Mandal P., Chaudhuri S., Sengupta A., Lakshmanaswamy R., Chakrabarti P, Roy S and Das C*. 2020. Suppression of poised oncogenes by ZMYND8 promotes chemo-sensitization. Cell Death Dis. 11(12):1073. JIF: 6.484
     

  5. Sanyal S, Mondal P, Sen S, Sengupta Bandyopadhyay S, Das C. 2020. SUMO E3 ligase CBX4 regulates hTERT-mediated transcription of CDH1 and promotes breast cancer cell migration and invasion. Biochem J. 477(19):3803-3818. JIF: 4.12
     

  6. Srivastava DK, Gunjan S, Das C, Seshadri V, Roy S. 2021. Structural insights into histone chaperone Asf1 and its characterization from Plasmodium falciparum. Biochem J. 478(5):1117-1136. JIF: 4.12
     

  7. Karmakar D, Maity J, Mondal P, Shyam Chowdhury P, Sikdar N, Karmakar P, Das C, Sengupta S. 2020. E2F5 promotes prostate cancer cell migration and invasion through regulation of TFPI2, MMP-2 and MMP-9. Carcinogenesis. 41(12):1767-1780. JIF: 4.646
     

  8. Mondal P., Sen S., Klein B.J., Tiwary N., Gadad S.S., Kutateladze T.G., Roy S. and Das C*. 2020. TCF19 promotes cell proliferation through binding to the histone H3K4me3 mark. Biochemistry. 59(4):389. JIF: 2.952
    *Accepted for Supplementary Cover Page Publication

     

  9. Mukherjee S, Sen S, Adhikary S, Sengupta A, Mandal P, Dasgupta D, Chakrabarti P, Roy S and Das C*. 2020. A novel role of tumor suppressor ZMYND8 in inducing differentiation of breast cancer cells through its dual histone binding function.
    J Biosci. 45. pii:2. JIF: 1.823
    *Published by Indian Academy of Sciences as a Special Issue

     

  10. Adhikary S., Chakravarti D., Terranova C., Sengupta I., Maitituoheti M., Dasgupta A., Srivastava D.K., Ma J., Raman A.T., Tarco E., Sahin A. A., Bassett R., Yang F., Tapia C., Roy S.*, Rai K.* and Das C*. 2019. Atypical Plant Homeodomain of UBR7 Functions as an H2BK120Ub Ligase and Breast Tumor Suppressor. Nat Commun. 10(1):1398. JIF: 13.691
     

  11. Chakraborty B, Mondal P, Gajendra P, Mitra M, Das C, Sengupta S. 2018. Deciphering genetic regulation of CD14 by SP1 through characterization of peripheral blood mononuclear transcriptome of P. faiciparum and P. vivax infected malaria patients. EBioMedicine. 37:442-452. JIF: 6.183
     

  12. Ray T, Kar D, Pal A, Mukherjee S, Das C, Pal A. 2018. Molecular targeting of breast and colon cancer cells by PAR1 mediated apoptosis through a novel pro-apoptotic peptide. Apoptosis. 23(11-12):679-694. JIF: 3.967
     

  13. Sau A., Sanyal S., Bera K., Sen S., Mitra A.K., Pal U., Chakraborty P.K., Ganguly S., Satpati B., Das C*. and Basu S.* 2018. DNA Damage and Apoptosis Induction in Cancer Cells by Chemically Engineered Thiolated Riboflavin Gold Nanoassembly.
    ACS Appl Mater Interfaces, 10(5):4582-4589. JIF: 7.504

     

  14. Sengupta I., Das D., Singh S.P., Chakravarty R. and Das C*. 2017. Host transcription factor Speckled 110 kDa (Sp110), a nuclear body protein, is hijacked by Hepatitis B virus protein X for viral persistence. J Biol Chem., 292(50):20379-20393. JIF: 4.403
     

  15.  Sen S., Sanyal S., Srivastava D.K., Dasgupta D., Roy S. and Das C*. 2017. Transcription factor 19 regulates gluconeogenesis in concert with the nucleosomeremodelling-deacetylase complex via histone 3 lysine 4 trimethylation recognition. J Biol Chem., 292(50):20362-20378. JIF: 4.403
    *Accepted for Cover Page Publication

     

  16. Basu M., Sengupta I., Khan W., Srivastava D.K., Chakrabarti P., Roy S. and Das C*. 2017. Dual histone reader ZMYND8 inhibits cancer cell invasion by positively regulating epithelial genes. Biochem J., 474(11):1919-1934. JIF: 4.12
     

  17. Goswami S., Sanyal S., Chakraborty P., Das C.*, Sarkar M.* 2017. Interaction of a Common Painkiller Piroxicam and Copper-piroxicam with Chromatin Causes Structural Alterations Accompanied by Modulation at the Epigenomic/Genomic level.
    Biochim Biophys Acta- Gen Subj. 4165(17)30131-30139. JIF: 5.08

     

  18. Basu M., Khan M.W., Chakrabarti P. and Das C*, 2017. Chromatin reader ZMYND8 is a key target of all trans retinoic acid-mediated inhibition of cancer cell proliferation. Biochim Biophys Acta- Gene Regul Mech. 1860(4):450-459. JIF: 5.550 
     

  19. Das D., Sengupta I., Sarkar N., Pal A., Saha D., Bandopadhyay M., Das C., Narayan J., Singh S.P., Chakrabarti S., Chakravarty R.. 2017. Anti-hepatitis B virus (HBV) response of imiquimod based toll like receptor 7 ligand in hbv-positive human hepatocelluar carcinoma cell line. BMC Infect Dis., 17(1):76. JIF: 2.864
     

  20. Das D., Sarkar N., Sengupta I., Pal A., Saha D., Bandopadhyay M., Das C., Narayan J., Singh S.P., Chakravarty R. 2016. Anti-viral role of toll like receptor 4 in hepatitis B virus infection: An in vitro study.
    World J Gastroenterol., 22(47):10341-10352. JIF: 2.848

     

  21. Bandopadhyay M., Sarkar N., Datta S., Das D., Pal A., Panigrahi R., Banerjee A., Panda C.K., Das C., Chakrabarti S., Chakravarty R. 2016. Hepatitis B virus X protein mediated suppression of miRNA-122 expression enhances hepatoblastoma cell proliferation through cyclin G1-p53 axis. Infect Agent Cancer. 11:40. JIF: 1.718
     

  22. Banerjee A., Sanyal S., Dutta S., Chakraborty P., Das P.P., Jana K., Vasudevan M., Das C.*, Dasgupta D.*. 2016. The plant alkaloid chelerythrine binds to chromatin, alters H3K9Ac and modulates global gene expression.
    J Biomol Struct Dyn. 35(7):1491-1499. JIF: 2.689

     

  23. Adhikary S., Sanyal S., Basu M., Sengupta I., Sen S., Srivastava D.K., Roy S.* and Das C.* 2016. Selective Recognition of H3.1K36 dimethylation / H4K16 acetylation facilitates the regulation of ATRA-responsive genes by putative chromatin reader ZMYND8. J Biol Chem., 291:2664-2681. JIF: 4.403
     

  24. Chakrabarti R., Sanyal S., Ghosh A., Bhar K., Das C.* and Siddhanta A.* 2015. Phosphatidylinositol 4-phosphate 5-kinase 1-alpha modulates ribosomal RNA gene silencing through its interaction with histone H3 lysine 9 trimethylation and heterochromatin protein HP1-alpha. J Biol Chem. 290:20893-20903. JIF: 4.403
     

  25. Banerjee A., Sanyal S., Majumder P., Chakraborty P., Jana K., Das C.*, Dasgupta D.* 2015. Recognition of chromatin by the plant alkaloid, ellipticine as a dual binder. Biochem Biophys Res Commun., 462:352-357. JIF: 2.392
     

  26. Kulkarni K.K., Bankar K.G., Shukla R.N., Das C, Banerjee A, Jana K, Dasgupta D, Vasudevan M. 2014. Global gene expression profiling data analysis reveals key gene families and biological processes inhibited by Mithramycin in sarcoma cell lines.
    Genom Data, 3:8-14. SCImago Journal Rank (SJR): 0.584

     

  27. Banerjee A., Sanyal S., Kulkarni K.K., Jana K., Roy S., Das C.*, Dasgupta D.* 2014. Anticancer drug mithramycin interacts with core histones: an additional mode of action of the DNA groove binder. FEEBS Open Bio. 4:987-995. JIF: 2.143
     

  28. Das C., Roy S., Namjoshi S., Malarkey C.S., Jones D.N., Kutateladze T.G., Churchill M.E. and Tyler J.K. 2014. Binding of the histone chaperone ASF1 to the CBP bromodomain promotes histone acetylation. Proc Natl Acad Sci U S A., 111(12): E1072-81. JIF: 10.285
     

  29. Banerjee A., Majumder P., Sanyal S., Singh J., Jana K., Das C.*, Dasgupta D.* 2014. The DNA intercalators ethidium bromide and propidium iodide also bind to core histones. FEBS Open Bio., 4:251-9. JIF: 2.143
     

  30. Feser J., Truong D., Das C., Carson J.J, Kieft J., Harkness T., and Tyler J.K. 2010. Elevated histone expression promotes lifespan extension. Mol. Cell, 39(5):724-35. JIF: 14.708
     

  31. Das C., Gadad S.S., and Kundu T.K. 2010. Human positive coactivator 4 controls heterochromatinization and silencing of neural gene expression by interacting with REST/NRSF and CoREST. J Mol Biol., 397(1):1-12. JIF: 4.632
     

  32. Ransom M., Williams S.K., Dechassa M.L., Das C., Linger J., Adkins M., Liu C., Bartholomew B., and Tyler J.K. 2009. FACT and the proteasome promote promoter chromatin disassembly and transcriptional initiation.
    J Biol Chem., 284(35):23461-71. JIF: 4.403

     

  33. Das C., Lucia M.S., Hansen K.C., and Tyler J.K. 2009. CBP/p300- mediated acetylation of histone H3 on Lysine 56. Nature, 459(7243):113-7 (Commentaries in Nature and Faculty of 1000 Biology) JIF: 41.458
     

  34. Selvi B.R., Pradhan S.K., Shandilya J., Das C., Sailaja B.S., Shankar G.N., Gadad S.S., Dasgupta D., and Kundu T.K. 2009. Putative anticancer therapeutic, Sanguinarine interacts with chromatin; modulates epigenetic modifications and chromatin transcription. Chem Biol., 16(2):203-16. JIF: 6.480
     

  35. Kishore A.H., Batta K., Das C., Agarwal S., and Kundu T.K. 2007. p53 Regulates Its Own Activator - Transcriptional Coactivator PC4: A New p53 Responsive Gene. Biochem J., 406(3), 437-444. JIF: 4.116
     

  36. Mantelingu K., Kishore A.H., Balasubramanyam K., Kumar G.V., Altaf M., Swamy S.M., Selvi B.R., Das C., Narayana C., Rangappa K.S., and Kundu T.K. 2007. Activation of p300 histone acetyltransferase by Small molecules altering Enzyme Structure: Probed by Surface Enhanced Raman Spectroscopy. J Phys Chem B., 111(17), 4527-4534. JIF: 3.265
     

  37. Das C., Hizume K., Batta K., Kumar B.R., Gadad S.S., Ganguly S., Lorain S., Verreault A., Sadhale P.P., Takeyasu K., and Kundu T.K. 2006. Transcriptional Coactivator PC4, A Chromatin-associated Protein, Induces Chromatin Condensation. Mol Cell Biol., 26(22), 8303-8315. JIF: 4.782
     

Reviews
  1. Adhikari S, Bhattacharya A, Adhikary S, Singh V, Gadad SS, Roy S, Das C*. 2022. The paradigm of drug resistance in cancer: an epigenetic perspective. Biosci Rep. 2022 Apr 29;42(4):BSR20211812.
     

  2. Mondal A, Bhattacharya A, Singh V, Pandita S, Barcolla A, Pandita RK, Tainer JA, Ramos KS, Pandita TK*, Das C*. 2022. Stress Responses as Master Keys to Epigenomic Changes in Transcriptome and Metabolome for Cancer Etiology and Therapeutics. Mol Cell Biol. 2022 Jan 20;42(1):e0048321.

  3. Adhikary S, Roy S, Chacon J, Gadad S.S. and Das C. 2021. Implications of enhancer transcription and eRNAs in cancer.
    Cancer Res. (In Press). JIF: 9.727

     

  4. Sedano MJ, Harrison AL, Zilaie M, Das C, Choudhari R, Ramos E, Gadad SS. 2020. Emerging Roles of Estrogen-Regulated Enhancer and Long Non-Coding RNAs. Int J Mol Sci., 21(10):3711. JIF: 4.653
     

  5. Sen S, Das C*. 2018. Managing the sugar factory: A new feather in the cap for nuclear factor Y.
    J Biol Chem. 293(20):7905-7906. JIF: 4.403.

     

  6. Das C., and Tyler J.K. 2013. Histone exchange and histone modifications during transcription and aging. Biochim Biophys Acta, Special issue: Histone chaperones and Chromatin assembly, 1819(3-4): 332-42. JIF: 3.595
     

  7. Das C., Tyler J.K., and Churchill M.E. 2010. The histone shuffle: histone chaperones in an energetic dance. Trends Biochem Sci., 35(9):476-89. JIF: 13.026
    *Accepted for Cover Page publication

     

  8. Das C., and Kundu T.K. 2005. Transcriptional regulation by the acetylation of nonhistone proteins in humans- a new target for therapeutics. IUBMB Life, 57(3), 137- 149. JIF: 3.257

Book Chapters
  1. Mukherjee S., Adhikary S., Roy S. and Das C.* 2017. Noncoding RNAs as chromatin scaffold of histone modification complexes in cancer. In Cancer and Non-coding RNAs, Translational Epigenetics Series, Volume eds: Jayprokas Chakrabarti and Sanga Mitra; Series ed: Trygve Tollefsbol, (Elsevier), 1: 330-352
     

  2. Kumari S., Das C., Sikder S., Kumar M., Bachu M., Ranga U. and Kundu T.K. 2015. Identification and characterization of nonhistone chromatin proteins: human positive coactivator 4 as a candidate. In Chromatin Protocols, ed: Srikumar P. Chellappan, (Springer) Methods Mol. Biol., 1288: 245-72.
     

  3. Batta K., Das C., Gadad S., Shandilya J., and Kundu T.K. 2007. Reversible acetylation of nonhistone proteins: Role in cellular functions and diseases. Subcell Biochem. In Chromatin and Disease, eds: T. K. Kundu and D. Dasgupta, (Springer). 41:193–212

bottom of page